BrightAccountsProduction v1.0.0 v1.0.0 2025-01-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is that of asset management of health care related real estate. 13 July 2026 0 0 11534616 2025-12-31 11534616 2024-12-31 11534616 2023-12-31 11534616 2025-01-01 2025-12-31 11534616 2024-01-01 2024-12-31 11534616 uk-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 11534616 uk-curr:PoundSterling 2025-01-01 2025-12-31 11534616 uk-bus:AbridgedAccounts 2025-01-01 2025-12-31 11534616 uk-core:ShareCapital 2025-12-31 11534616 uk-core:ShareCapital 2024-12-31 11534616 uk-core:RetainedEarningsAccumulatedLosses 2025-12-31 11534616 uk-core:RetainedEarningsAccumulatedLosses 2024-12-31 11534616 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-12-31 11534616 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-12-31 11534616 uk-core:RetainedEarningsAccumulatedLosses 2025-01-01 2025-12-31 11534616 uk-bus:FRS102 2025-01-01 2025-12-31 11534616 uk-core:PlantMachinery 2025-01-01 2025-12-31 11534616 2025-01-01 2025-12-31 11534616 uk-bus:Director2 2025-01-01 2025-12-31 11534616 uk-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
Waypoint Health Property Limited
 
Abridged Unaudited Financial Statements
 
for the financial year ended 31 December 2025



Waypoint Health Property Limited
DIRECTORS' REPORT
for the financial year ended 31 December 2025

 
The directors present their report and the unaudited financial statements for the financial year ended 31 December 2025.
 
Principal Activity
The principal activity of the company is that of asset management of health care related real estate.
     
Directors
The directors who served during the financial year are as follows:
     
Mr Michael Edward Riley
Mr Nicholas John Gregory
Mr Spencer Adrian Kenyon (Resigned 22 January 2026)
Mr Andrew Simon Darke (Resigned 22 January 2026)
   
     
Political Contributions
The company did not make any disclosable political donations in the current financial year.
     
Statement of Directors' Responsibilities
     
The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations.
     

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

- select suitable accounting policies and apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
     
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
     
___________________________
Mr Nicholas John Gregory
Director
     
13 July 2026



Waypoint Health Property Limited
ABRIDGED PROFIT AND LOSS ACCOUNT
for the financial year ended 31 December 2025
2025 2024
Notes £ £

Gross profit 157,990 187,010
 
Distribution costs (611) (1,403)
Administrative expenses (171,994) (172,017)
───────── ─────────
Operating (loss)/profit (14,615) 13,590
 
Interest receivable and similar income - 89
Interest payable and similar expenses (30) -
───────── ─────────
(Loss)/profit before taxation (14,645) 13,679
 
Tax on (loss)/profit 338 (2,597)
───────── ─────────
(Loss)/profit for the financial year (14,307) 11,082
───────── ─────────
Total comprehensive income (14,307) 11,082
    ═════════   ═════════



Waypoint Health Property Limited
Company Registration Number: 11534616
ABRIDGED BALANCE SHEET
as at 31 December 2025

2025 2024
Notes £ £
 
Fixed Assets
Tangible assets 4 (1) 1,353
───────── ─────────
 
Current Assets
Debtors 26,562 29,825
Cash and cash equivalents 15,894 29,949
───────── ─────────
42,456 59,774
───────── ─────────
Creditors: amounts falling due within one year (2,616) (6,643)
───────── ─────────
Net Current Assets 39,840 53,131
───────── ─────────
Total Assets less Current Liabilities 39,839 54,484
 
Provisions for liabilities - (338)
───────── ─────────
Net Assets 39,839 54,146
═════════ ═════════
 
Capital and Reserves
Called up share capital 50,000 50,000
Retained earnings (10,161) 4,146
───────── ─────────
Equity attributable to owners of the company 39,839 54,146
═════════ ═════════
 
These abridged financial statements have been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Board and authorised for issue on 13 July 2026 and signed on its behalf by
           
           
________________________________          
Mr Nicholas John Gregory          
Director          
           



Waypoint Health Property Limited
STATEMENT OF CHANGES IN EQUITY
as at 31 December 2025

Called up Retained Total
share earnings
capital
£ £ £
 
At 1 January 2024 - (6,936) (6,936)
───────── ───────── ─────────
Profit for the financial year - 11,082 11,082
───────── ───────── ─────────
At 31 December 2024 50,000 4,146 54,146
  ───────── ───────── ─────────
Loss for the financial year - (14,307) (14,307)
  ───────── ───────── ─────────
At 31 December 2025 50,000 (10,161) 39,839
  ═════════ ═════════ ═════════



Waypoint Health Property Limited
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 31 December 2025

   
1. General Information
 
Waypoint Health Property Limited is a company limited by shares incorporated and registered in the England and Wales. The registered number of the company is 11534616. The registered office of the company is 4th Floor, 17-19 Maddox Street, London, W1S 2QH, United Kingdom which is also the principal place of business of the company. The principal activity of the company is that of asset management of health care related real estate. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 31 December 2025 have been prepared in accordance with the Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland (FRS 102) issued by the Financial Reporting Council and in accordance with the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Cash flow statement
The company has availed of the exemption in FRS 102 from the requirement to prepare a Statement of Cash Flows because it is classified as a small company.
 
Turnover
Turnover comprises the invoice value of services supplied by the company, exclusive of trade discounts and value added tax, arising from te principal activity of the company.
 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. Cost comprises purchase price and other directly attributable costs. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Plant and machinery - 25% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Work in progress
Work in progress is reflected in the accounts at the expected revenue due for work carried out during the period that has not yet been invoiced.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Provisions
Provisions are recognised when the company has a present legal or constructive obligation arising as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and a reliable estimate can be made. Provisions are measured at the present value of the expenditures expected to be required to settle the obligation using a pre-tax rate that reflects current market assessments of the same value of money and the risks specific to the obligation. The increase in the provision due to passage of time is recognised as interest expense.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Taxation and deferred taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements.

Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.

 
Research and development
Development expenditure is written off to the Profit and Loss Account in the financial year in which it is incurred.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including directors, during the financial year was 0, (2024 - 0).
       
4. Tangible assets
  Plant and Total
  machinery  
     
  £ £
Cost
At 1 January 2025 6,015 6,015
  ───────── ─────────
 
At 31 December 2025 6,015 6,015
  ───────── ─────────
Depreciation
At 1 January 2025 4,662 4,662
Charge for the financial year 1,354 1,354
  ───────── ─────────
At 31 December 2025 6,016 6,016
  ───────── ─────────
Net book value
At 31 December 2025 (1) (1)
  ═════════ ═════════
At 31 December 2024 1,353 1,353
  ═════════ ═════════
       
5. Capital commitments
 
The company had no material capital commitments at the financial year-ended 31 December 2025.
   
6. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.